The Renal and Systemic Hemodynamic Effects of a Nitric Oxide-Synthase Inhibitor Are Reversed by a Selective EndothelinA Receptor Antagonist in Men
- 31 August 2001
- journal article
- clinical trial
- Published by Elsevier in Nitric Oxide
- Vol. 5 (4) , 370-376
- https://doi.org/10.1006/niox.2001.0357
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Endothelin-A Blockade Attenuates Systemic and Renal Hemodynamic Effects of L-NAME in HumansHypertension, 2000
- Endothelin and angiotensin mediate most glomerular responses to nitric oxide inhibitionKidney International, 1999
- Endothelial Dysfunction in Human DiseaseJournal of Molecular and Cellular Cardiology, 1999
- Systemic and renal effects of an ETA receptor subtype‐specific antagonist in healthy subjectsBritish Journal of Pharmacology, 1998
- Importance of nitric oxide in the control of renal hemodynamicsKidney International, 1996
- Glomerular actions of nitric oxideKidney International, 1995
- Inhibition of ETB Receptors Limits the Efficacy of Nonselective Endothelin Antagonists In VivoJournal of Cardiovascular Pharmacology, 1995
- Nitric oxide regulates basal systemic and pulmonary vascular resistance in healthy humans.Circulation, 1994
- Inhibition of nitric oxide synthesis increases blood pressure in healthy humansJournal Of Hypertension, 1993
- Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failureThe Lancet, 1992